- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.5: 13 residues within 4Å:- Chain A: L.327, V.330, L.334, Q.374, N.377, I.378, V.381, F.385
- Chain B: V.472, L.473, I.476
- Ligands: UMQ.8, UMQ.10
15 PLIP interactions:12 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:L.327, A:V.330, A:V.330, A:L.334, A:I.378, A:V.381, A:V.381, A:F.385, A:F.385, B:V.472, B:L.473, B:I.476
- Hydrogen bonds: A:Q.374, A:Q.374, A:N.377
CLR.18: 13 residues within 4Å:- Chain B: L.327, V.330, L.334, Q.374, N.377, I.378, V.381, F.385
- Chain C: V.472, L.473, I.476
- Ligands: UMQ.21, UMQ.23
15 PLIP interactions:12 interactions with chain B, 3 interactions with chain C- Hydrophobic interactions: B:L.327, B:V.330, B:V.330, B:L.334, B:I.378, B:V.381, B:V.381, B:F.385, B:F.385, C:V.472, C:L.473, C:I.476
- Hydrogen bonds: B:Q.374, B:Q.374, B:N.377
CLR.28: 13 residues within 4Å:- Chain C: L.327, V.330, L.334, Q.374, N.377, I.378, V.381, F.385
- Chain D: V.472, L.473, I.476
- Ligands: UMQ.31, UMQ.33
14 PLIP interactions:12 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:L.327, C:V.330, C:V.330, C:L.334, C:I.378, C:V.381, C:V.381, C:F.385, C:F.385, D:V.472, D:I.476
- Hydrogen bonds: C:Q.374, C:Q.374, C:N.377
CLR.39: 13 residues within 4Å:- Chain A: V.472, L.473, I.476
- Chain D: L.327, V.330, L.334, Q.374, N.377, I.378, V.381, F.385
- Ligands: UMQ.42, UMQ.44
14 PLIP interactions:12 interactions with chain D, 2 interactions with chain A- Hydrophobic interactions: D:L.327, D:V.330, D:V.330, D:L.334, D:I.378, D:V.381, D:V.381, D:F.385, D:F.385, A:V.472, A:I.476
- Hydrogen bonds: D:Q.374, D:Q.374, D:N.377
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 3 residues within 4Å:- Chain A: N.145, E.160, Y.162
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.145, A:E.160
NAG.7: 3 residues within 4Å:- Chain A: P.177, N.179, N.229
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:P.177
- Hydrogen bonds: A:N.229
NAG.19: 3 residues within 4Å:- Chain B: N.145, E.160, Y.162
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.145, B:E.160
NAG.20: 3 residues within 4Å:- Chain B: P.177, N.179, N.229
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:P.177
- Hydrogen bonds: B:N.229
NAG.29: 3 residues within 4Å:- Chain C: N.145, E.160, Y.162
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.145, C:E.160
NAG.30: 3 residues within 4Å:- Chain C: P.177, N.179, N.229
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:P.177
- Hydrogen bonds: C:N.229
NAG.40: 3 residues within 4Å:- Chain D: N.145, E.160, Y.162
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.145, D:E.160
NAG.41: 3 residues within 4Å:- Chain D: P.177, N.179, N.229
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:P.177
- Hydrogen bonds: D:N.229
- 32 x UMQ: UNDECYL-MALTOSIDE(Non-covalent)
UMQ.8: 14 residues within 4Å:- Chain A: H.196, W.197, Q.273, Y.370, I.373, Q.374, N.377
- Chain B: A.469, N.470, R.471, V.472
- Ligands: CLR.5, UMQ.10, UMQ.11
Ligand excluded by PLIPUMQ.9: 13 residues within 4Å:- Chain A: L.51, L.54, M.58, Y.282, E.294, F.297, A.338, I.339, N.342, I.343, S.347, F.375, A.379
Ligand excluded by PLIPUMQ.10: 7 residues within 4Å:- Chain A: W.197, T.202
- Chain B: V.472, I.476
- Ligands: CLR.5, UMQ.8, UMQ.12
Ligand excluded by PLIPUMQ.11: 9 residues within 4Å:- Chain A: S.194, S.195, V.333, L.334, H.367, Y.370, W.371, Q.374
- Ligands: UMQ.8
Ligand excluded by PLIPUMQ.12: 7 residues within 4Å:- Chain A: W.197, Q.447, F.451
- Chain B: R.471, P.475, I.476
- Ligands: UMQ.10
Ligand excluded by PLIPUMQ.13: 10 residues within 4Å:- Chain A: L.426, Q.430, Y.433, F.446
- Chain D: T.55, Y.56, M.59, S.60, S.61, W.387
Ligand excluded by PLIPUMQ.14: 9 residues within 4Å:- Chain A: F.323, W.324, I.388, F.391, S.404, M.407, S.408
- Chain B: I.424
- Ligands: UMQ.15
Ligand excluded by PLIPUMQ.15: 4 residues within 4Å:- Chain A: F.323, S.408, A.411
- Ligands: UMQ.14
Ligand excluded by PLIPUMQ.16: 9 residues within 4Å:- Chain A: T.55, Y.56, M.59, S.61, W.387
- Chain B: L.426, Q.430, Y.433, F.446
Ligand excluded by PLIPUMQ.21: 14 residues within 4Å:- Chain B: H.196, W.197, Q.273, Y.370, I.373, Q.374, N.377
- Chain C: A.469, N.470, R.471, V.472
- Ligands: CLR.18, UMQ.23, UMQ.24
Ligand excluded by PLIPUMQ.22: 12 residues within 4Å:- Chain B: L.51, L.54, Y.282, E.294, F.297, A.338, I.339, N.342, I.343, S.347, F.375, A.379
Ligand excluded by PLIPUMQ.23: 7 residues within 4Å:- Chain B: W.197, T.202
- Chain C: V.472, I.476
- Ligands: CLR.18, UMQ.21, UMQ.25
Ligand excluded by PLIPUMQ.24: 9 residues within 4Å:- Chain B: S.194, S.195, V.333, L.334, H.367, Y.370, W.371, Q.374
- Ligands: UMQ.21
Ligand excluded by PLIPUMQ.25: 7 residues within 4Å:- Chain B: W.197, Q.447, F.451
- Chain C: R.471, P.475, I.476
- Ligands: UMQ.23
Ligand excluded by PLIPUMQ.26: 9 residues within 4Å:- Chain B: F.323, W.324, I.388, F.391, S.404, M.407, S.408
- Chain C: I.424
- Ligands: UMQ.27
Ligand excluded by PLIPUMQ.27: 4 residues within 4Å:- Chain B: F.323, S.408, A.411
- Ligands: UMQ.26
Ligand excluded by PLIPUMQ.31: 14 residues within 4Å:- Chain C: H.196, W.197, Q.273, Y.370, I.373, Q.374, N.377
- Chain D: A.469, N.470, R.471, V.472
- Ligands: CLR.28, UMQ.33, UMQ.34
Ligand excluded by PLIPUMQ.32: 12 residues within 4Å:- Chain C: L.51, L.54, Y.282, E.294, F.297, A.338, I.339, N.342, I.343, S.347, F.375, A.379
Ligand excluded by PLIPUMQ.33: 7 residues within 4Å:- Chain C: W.197, T.202
- Chain D: V.472, I.476
- Ligands: CLR.28, UMQ.31, UMQ.35
Ligand excluded by PLIPUMQ.34: 9 residues within 4Å:- Chain C: S.194, S.195, V.333, L.334, H.367, Y.370, W.371, Q.374
- Ligands: UMQ.31
Ligand excluded by PLIPUMQ.35: 7 residues within 4Å:- Chain C: W.197, Q.447, F.451
- Chain D: R.471, P.475, I.476
- Ligands: UMQ.33
Ligand excluded by PLIPUMQ.36: 9 residues within 4Å:- Chain B: T.55, Y.56, M.59, S.61, W.387
- Chain C: L.426, Q.430, Y.433, F.446
Ligand excluded by PLIPUMQ.37: 9 residues within 4Å:- Chain C: F.323, W.324, I.388, F.391, S.404, M.407, S.408
- Chain D: I.424
- Ligands: UMQ.38
Ligand excluded by PLIPUMQ.38: 4 residues within 4Å:- Chain C: F.323, S.408, A.411
- Ligands: UMQ.37
Ligand excluded by PLIPUMQ.42: 14 residues within 4Å:- Chain A: A.469, N.470, R.471, V.472
- Chain D: H.196, W.197, Q.273, Y.370, I.373, Q.374, N.377
- Ligands: CLR.39, UMQ.44, UMQ.45
Ligand excluded by PLIPUMQ.43: 12 residues within 4Å:- Chain D: L.51, L.54, Y.282, E.294, F.297, A.338, I.339, N.342, I.343, S.347, F.375, A.379
Ligand excluded by PLIPUMQ.44: 7 residues within 4Å:- Chain A: V.472, I.476
- Chain D: W.197, T.202
- Ligands: CLR.39, UMQ.42, UMQ.46
Ligand excluded by PLIPUMQ.45: 9 residues within 4Å:- Chain D: S.194, S.195, V.333, L.334, H.367, Y.370, W.371, Q.374
- Ligands: UMQ.42
Ligand excluded by PLIPUMQ.46: 7 residues within 4Å:- Chain A: R.471, P.475, I.476
- Chain D: W.197, Q.447, F.451
- Ligands: UMQ.44
Ligand excluded by PLIPUMQ.47: 9 residues within 4Å:- Chain C: T.55, Y.56, M.59, S.61, W.387
- Chain D: L.426, Q.430, Y.433, F.446
Ligand excluded by PLIPUMQ.48: 9 residues within 4Å:- Chain A: I.424
- Chain D: F.323, W.324, I.388, F.391, S.404, M.407, S.408
- Ligands: UMQ.49
Ligand excluded by PLIPUMQ.49: 4 residues within 4Å:- Chain D: F.323, S.408, A.411
- Ligands: UMQ.48
Ligand excluded by PLIP- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, Q. et al., Lipid Interactions of a Ciliary Membrane TRP Channel: Simulation and Structural Studies of Polycystin-2. Structure (2020)
- Release Date
- 2019-11-20
- Peptides
- Polycystin-2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 32 x UMQ: UNDECYL-MALTOSIDE(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, Q. et al., Lipid Interactions of a Ciliary Membrane TRP Channel: Simulation and Structural Studies of Polycystin-2. Structure (2020)
- Release Date
- 2019-11-20
- Peptides
- Polycystin-2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.